FDA approves questionable device
In a statement, Dr.
Peter Lurie, MD, MPH, deputy director of Public Citizen’s Health Research
Group, declared the US Food & Drug Administration’s decision to approve the
Vagus Nerve Stimulator (VNS) for treatment-resistant depression “one of its
most questionable regulatory decisions…in recent memory.” He went on to say,
“As a consequence of the FDA’s data-free decision-making, hundreds of
thousands of patients with severe depression are likely to undergo surgery
to implant a device that has not been proved to work.”
The
VNS is an electronic device implanted surgically at the base of the neck
that sends pulses of electricity into the brain and elsewhere in the body
every five minutes. It was deemed not-approvable by the FDA in August 2004
due to a lack of convincing evidence of its effectiveness and concerns that
it may actually worsen depression in some patients.
Its main clinical trial
proved a failure for the VNS. The FDA’s statistical reviewer judged the
other main analysis – by Cyberonics Inc., the device’s manufacturer – to be
“highly questionable.” Safety concerns, stemming from cases of worsening
depression, suicide and sudden death among patients who received the device
have not been addressed by adequately controlled long-term trials.
Yet, in the absence of
substantially new data, the FDA reversed its position and last month
approved the device. The Wall Street Journal reported in May that the
Senate Finance Committee was examining the FDA’s handling of Cyberonics’
application.
Devices for which
medical claims are made should meet the same approval criteria as drugs. In
effect, the FDA has lowered the approval bar for this device. Persuasive
evidence that the device works is lacking. Unless and until such data are
generated, patients are better off without it.
SOURCE:
“Approval of Device to Treat Depression Is One of Most Questionable FDA
Decisions in Recent Memory.” Statement of Peter Lurie, MD, MPH, deputy
director, Public Citizen’s Health Research Group. Public Citizen Media
Advisory, July 18, 2005.